Abstract:Identification of potential drug–associated indications is critical for either approved or novel drugs in drug repositioning. Current computational methods based on drug similarity and disease similarity have been developed to predict drug–disease associations. When more reliable drug- or disease-related information becomes available and is integrated, the prediction precision can be continuously improved. However, it is a challenging problem to effectively incorporate multiple types of prior information, representing different characteristics of drugs and diseases, to identify promising drug–disease associations. In this study, we propose an overlap matrix completion (OMC) for bilayer networks (OMC2) and tri-layer networks (OMC3) to predict potential drug-associated indications, respectively. OMC is able to efficiently exploit the underlying low-rank structures of the drug–disease association matrices. In OMC2, first of all, we construct one bilayer network from drug-side aspect and one from disease-side aspect, and then obtain their corresponding block adjacency matrices. We then propose the OMC2 algorithm to fill out the values of the missing entries in these two adjacency matrices, and predict the scores of unknown drug–disease pairs. Moreover, we further extend OMC2 to OMC3 to handle tri-layer networks. Computational experiments on various datasets indicate that our OMC methods can effectively predict the potential drug–disease associations. Compared with the other state-of-the-art approaches, our methods yield higher prediction accuracy in 10-fold cross-validation and <em>de novo</em> experiments. In addition, case studies also confirm the effectiveness of our methods in identifying promising indications for existing drugs in practical applications.This work introduces a computational approach, namely overlap matrix completion (OMC), to predict potential associations between drugs and diseases. The novelty of OMC lies in constructing an efficient framework of incorporating multiple types of prior information in bilayer and tri-layer networks. OMC for bilayer networks (OMC2) can approximate the low-rank structures of the drug–disease association matrices from both drug-side and disease-side. In addition, we further improve the prediction accuracy by extending OMC to handle tri-layer networks and develop its corresponding algorithm (OMC3). To evaluate the performance of OMC2 and OMC3, we conduct 10-fold cross-validation and <em>de novo</em> experiments on three datasets. Our computational results demonstrate that both OMC2 and OMC3 generally outperform five state-of-the-art methods in terms of ROC curve, PR curve, and top-ranked predictions.

Drug Repositioning Based on Multi-View Learning with Matrix Completion

Drug Repositioning Via Matrix Completion with Multi‐view Side Information

Computational Drug Repositioning Based on Multi-Similarities Bilinear Matrix Factorization.

Drug Repositioning Via Multi-view Representation Learning with Heterogeneous Graph Neural Network

A Novel Drug Repositioning Approach Based on Collaborative Metric Learning

A Flexible and Robust Multi-Source Learning Algorithm for Drug Repositioning

Computational drug repositioning using low-rank matrix approximation and randomized algorithms

DRIMC: an improved drug repositioning approach using Bayesian inductive matrix completion

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

Heterogeneous graph inference with matrix completion for computational drug repositioning

Prediction of drug–disease associations based on reinforcement symmetric metric learning and graph convolution network

Drug repositioning based on the target microRNAs using bilateral-inductive matrix completion

Machine learning for drug repositioning: Recent advances and challenges

Computational Drug Repositioning Using Collaborative Filtering Via Multi-Source Fusion

Predicting Drug-Disease Associations via Multi-Task Learning Based on Collective Matrix Factorization

Drug Repositioning Through Integration of Prior Knowledge and Projections of Drugs and Diseases

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

Overlap matrix completion for predicting drug-associated indications

An Effective Multi-Task Learning Framework for Drug Repurposing Based on Graph Representation Learning.

Predicting Associations among Drugs, Targets and Diseases by Tensor Decomposition for Drug Repositioning

Drug Repositioning by Multi-Aspect Heterogeneous Graph Contrastive Learning and Positive-Fusion Negative Sampling Strategy